Rhythm Pharmaceuticals, Inc.
RYTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001649904
In the last 90 days, Rhythm Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $8.55B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Rhythm Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 115 | 126 | +11 |
| Shares | 62.3M | 60.3M | −1.98M (−3.2%) |
| Value | $1.81B | $1.08B | −$738.2M (−40.7%) |
New holders (29)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (18)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Invesco Ltd. | 334,273 | $9.73M |
| Altium Capital Management LP | 170,000 | $4.95M |
| EAM Investors, LLC | 164,695 | $4.80M |
| Parkman Healthcare Partners LLC | 157,862 | $4.60M |
| Ensign Peak Advisors, Inc | 108,562 | $3.16M |
| EAM Global Investors LLC | 62,623 | $1.82M |
| Bell & Brown Wealth Advisors, LLC | 41,600 | $1.21M |
| Candriam Luxembourg S.C.A. | 32,479 | $945.7K |
| Fred Alger Management, LLC | 19,988 | $582.1K |
| Campbell & CO Investment Adviser LLC | 19,535 | $568.9K |
| SEI Investments Co | 15,453 | $450.0K |
| American Century Companies Inc | 9,041 | $263.3K |
| Virginia Retirement Systems Et Al | 8,000 | $233.0K |
| Gsa Capital Partners LLP | 7,451 | $217.0K |
| 683 Capital Management, LLC | 6,960 | $202.7K |
| Simplex Trading, LLC | 5,581 | $162.0K |
| Sierra Capital LLC | 2,400 | $70.0K |
| Vigilant Capital Management, LLC | 100 | $3.00K |